Psychological health, access to care, expanded and personalized treatment options and the tracking of hypoglycemia emphasized.

New recommendation based on results from two large clinical trials for patients with diabetes and CVD.

Clinically significant hypoglycemia redefined, bariatric surgery renamed.

Guest Post by David Kliff, Diabetic Investor
Dexcom (NASDAQ: DXCM) received FDA approval for non-adjunctive claim.

What physiological feature puts East Asians at increased risk for type 2 diabetes? 1. Greater insulin resistance 2. Lower levels of endogenous incretins 3. Increased beta-cell dysfunction 4. Increased incidence of dyslipidemias Did you get it right? Follow the link to see the correct answer!

What percentage of your patients have a difficult time following their diabetes treatment regimen? 1) Greater than 75% 2) Greater than 50% 3) Less than 50% 4) Less than 25% Follow the link to share your opinion!

Yes, it’s that time of year again when your phone/email/computer is busy with patients wanting appointments and making commitments to make their New Year’s Resolutions. Often at this time of the year, my patients come in wanting to change just about everything about what they eat, when they eat, how much they eat, and the same for being physically active. So many of these patients have told me they have tried and tried and tried and failed in the past, but now it’s the New Year and it’s going to be different.

In this week's Homerun Slides, the baseline characteristics of the randomized, placebo-controlled cardiovascular outcome trial of empagliflozin.

Potential mechanisms of incretin dysfunction in type 2 diabetes: Various potential explanations have been expounded in order to explain the reduced incretin effect in type 2 diabetes. One obvious factor to examine was the secretion of GIP and GLP-1. Regarding GIP, a number of studies have compared postprandial plasma concentrations between patients with and without diabetes. These studies have revealed increased, normal, or reduced GIP levels in patients with diabetes. Considering all studies together, there does not appear to be a general defect in GIP secretion. If anything, a slight increase in postprandial GIP levels might occur in patients with early type 2 diabetes, but clearly the differences in GIP levels would not sufficiently explain any alterations in insulin of glucose concentrations.

To view this video in full, click here. Steve Freed: Maybe start off by telling us a little bit about yourself because you have an interesting background. Dr. Mechanick: I’m a clinical endocrinologist in private practice in New York City and an attending and clinical professor at Mount Sinai, at the Icon …